𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Survival Of Patients With Advanced Melanoma In A Real World Setting

✍ Scribed by Malinowski, F.J.; McGuire, M.; Wolthoff, P.; Macahilig, C.P.; Bennett, K.; Wong, S.L.; Penrod, J.R.

Book ID
122203215
Publisher
John Wiley and Sons
Year
2013
Tongue
English
Weight
72 KB
Volume
16
Category
Article
ISSN
1098-3015

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Single-institution experience with ipili
Single-institution experience with ipilimumab in advanced melanoma patients in the compassionate use setting : Lymphocyte count after 2 doses correlates with survival
✍ Geoffrey Y. Ku; Jianda Yuan; David B. Page; Sebastian E. A. Schroeder; Katherine πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 296 KB

## Abstract ## BACKGROUND: Ipilimumab is a monoclonal antibody that antagonizes cytotoxic T lymphocyte antigen‐4, a negative regulator of the immune system. The authors report on advanced refractory melanoma patients treated in a compassionate use trial of ipilimumab at the Memorial Sloan‐Ketterin